CTIM-02. TIP: PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES
Ontology highlight
SUBMITTER:
PROVIDER: S-EPMC9661020 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA